Cetp inhibitors

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 403/02 (2006.01) A61K 31/421 (2006.01) A61K 31/4439 (2006.01) C07D 263/16 (2006.01)

Patent

CA 2635083

Compounds having the structure of Formula (I), including pharmaceutically acceptable salts of the compounds, are CETP inhibitors and are useful for raising HDL-cholesterol, reducing LDL-cholesterol, and for treating or preventing atherosclerosis. In the compounds of Formula (I), B is a cyclic group other than phenyl, and B has a cyclic substituent at a position that is ortho to the position at which B is connected to the remainder of the structure of Formula (I). The 5-membered ring of Formula (I) has a second cyclic substituent in addition to B.

Des composés à structure de formule (I), y compris des sels pharmaceutiquement acceptables de ces composés, sont des inhibiteurs de CETP qui s'avèrent utiles pour augmenter le cholestérol HDL, réduire le cholestérol LDL, traiter ou prévenir l'athérosclérose. Dans les composés de formule (I), B est un groupe cyclique autre que phényle et B a un substituant cyclique en position ortho relativement à la position où B est lié au résidu de la structure de formule (I). Le noyau à 5 membres de formule (I) a un deuxième substituant cyclique en plus de B.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Cetp inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cetp inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cetp inhibitors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1524687

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.